Cytori Therapeutics Inc Share Price Nasdaq
Equities
US23283K1051
Biotechnology & Medical Research
Sales 2024 * | 3.4M 284M | Sales 2025 * | 4.28M 357M | Capitalization | 7.44M 621M |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.59B | Net income 2025 * | -22M -1.84B | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.74 x |
P/E ratio 2024 * |
-0.76
x | P/E ratio 2025 * |
-0.92
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.77% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/02/01 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06/20/06 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27/23/27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/02/01 |
Richard Hawkins
CHM | Chairman | 75 | 01/07/01 |
Robert Lenk
BRD | Director/Board Member | 75 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |